Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements

Download results of this page

Refine by:

Advanced search

Search projects and results

Results 1 - 10 of 13
12 > 
Strengthen and develop scientific and technological excellence in research and therapy of leukemia (CML, AML, ALL, CLL, MDS, CMPD) by integration of the leading national leukemia networks and their interdisciplinary partner groups in Europe
ID: 503216
Start date: 2004-01-01, End date: 2011-02-28
Leukemias are a challenge to society and a cost factor because of their frequency in all age groups. They also serve as a model for a variety of diseases and possess exemplary relevance for basic research and patient care. Leukemia research and therapy have achieved high stand...
Record Number: 75278
Last updated on: 2011-04-05
Boosting 4 ACC NCPs and their customers to advanced partnership, entrepreneurship and competitiveness for FP6 participation through expanded area of action by networking, training and coaching
ID: 510408
Start date: 2004-06-01, End date: 2007-01-31
In FP5 the National Contact Points (NCP) system was put into place in Member States (MS) and the Associated Candidate Countries (ACC). Boosting Baltic FP6 will increase NCP competences on FP6 programs and related knowledge and expand the NCP area of action. Boosting Baltic FP6...
Record Number: 75665
Last updated on: 2010-01-04
Mentoring of lifescihealth-multipliers in the accession candidate countries
ID: 512010
Start date: 2005-01-01, End date: 2006-12-31
Exploiting methodologies, developed by them in the IST-Mentor project, EU multipliers, with the help of local NCPs for LifeSciHealth, will identify and mentor candidate LifeSciHealth multipliers, in 11 ACCs - BG, CZ, CY, EE, LT, LV, PL, RO, SI, SK, TR. The se LifeSciHealth mul...
Record Number: 75466
Last updated on: 2009-12-14
Supporting SME-academia collaboration in the area of biomedical research in FP7 through efficient matching facilities and tailor-made information with special focus on NMS and ACC
ID: 37292
Start date: 2007-02-01, End date: 2010-01-31
SMEs go Health is designed to support SMEs and academic researchers in the 7th EU-Framework Programme (FP7) in order to foster trans-European RTD collaboration. SMEs and researchers shall be encouraged and trained in view of establishing joint innovative research projects by u...
Record Number: 86284
Last updated on: 2013-03-26
European Network for the identification and validation of Antigens and biomarkers in Cancer and their application in clinical Tumour immunology
ID: 503306
Start date: 2005-01-01, End date: 2008-06-30
ENACT aims to identify markers of response and tumour antigens that associate with ovarian and prostate cancer and melanoma progression and resistance to immunotherapy. Prospective clinical material will be collected during the life of the programme and new and existing tumour...
Record Number: 74049
Last updated on: 2013-03-26
Design of zinc metalloenzyme targeted drugs using an integrated technology approach
ID: 37303
Start date: 2007-01-01, End date: 2010-06-30
The objective of DeZnIT is to develop and apply new methodology for the rational and accelerated design of novel drugs targeted against zinc-containing enzymes. These enzymes are key modulators of many serious human diseases including cancer, glaucoma, obesity, and rheumatoid ...
Record Number: 86233
Last updated on: 2013-03-26
Genetic and environmental determinants of melanoma: translation into behavioural change
ID: 18702
Start date: 2005-12-01, End date: 2011-05-31
GenoMEL, formerly known as the Melanoma Genetics Consortium, has focused on the identification of familial high penetrance melanoma genes. The joint programme of research has been very successful in the identification of susceptibility genes and developing joint data collectio...
Record Number: 84807
Last updated on: 2011-07-26
Ration design and standardized evaluation of novel genetic vaccines.
ID: 5246
Start date: 2005-01-01, End date: 2009-06-30
Recombinant viral vectors and virus-like particles are considered the most promising vehicles to deliver antigens in prophylactic and therapeutic vaccines against infectious diseases and cancer. Several potential vaccine designs exist but their cost-effective development cruel...
Record Number: 74040
Last updated on: 2013-03-26
Assessment of structural requirements in complement-mediated bactericidal events: Towards a global approach to the selection of new vaccine candidates
ID: 37325
Start date: 2007-01-01, End date: 2010-06-30
High throughput cloning and expression of large sets of genomic ORFs has become a preferred industrial strategy for genome-wide searches of new vaccine candidates. For invasive infections in particular, the aim is to find proteins eliciting antibodies capable of binding to the...
Record Number: 84964
Last updated on: 2010-10-20
Molecular phenotyping to accelerate genomic epidemiology
ID: 512066
Start date: 2004-10-01, End date: 2009-03-31
Epidemiologists, clinical trialists and experimental scientists are confronted with a wealth of potential opportunities for molecular phenotyping large numbers of biological samples obtained from cohorts, patients or animal models. The challenge now is to ensure that these too...
Record Number: 74085
Last updated on: 2009-11-04
12 > 
List retrieved on: 2017-09-25
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top